Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02258438 · ClinicalTrials.gov registry record · NA

Effect of Breaking up Prolonged Sitting on Metabolic Flexibility

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT02258438: Completed NA study, sponsored by University of Colorado, Denver.

NCT02258438 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02258438, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

The investigators propose in this project to determine the effect of 3 days of frequent interruption of prolonged sitting on metabolic health in healthy overweight sedentary adults (n=24), as compared to 3 days including a single long bout of isocaloric exercise or a control condition where subjects do not exercise but are subjected to prolonged sitting. The investigators believe that this proposed project will provide an initial evidence base for the health benefits of breaking up prolonged sitting with short bursts of moderate-intensity activity, like walking.

Primary Outcome

Total fat oxidation during the test day will be determined using whole-room indirect calorimetry. O2 consumption and CO2 production will be determined from the flow rates and differences in gas concentrations between air entering and air exiting the calorimeter as previously described

Interventions

  • BEHAVIORAL Uninterrupted sitting
  • BEHAVIORAL Sitting + 1 bout of activity
  • BEHAVIORAL Sitting + microbursts of activity

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2014-10-08
Est. Completion 2017-09
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT02258438 record still lists

NCT02258438 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which Uninterrupted sitting is the first listed.

NCT02258438 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02258438 about?

NCT02258438 is a clinical study titled "Effect of Breaking up Prolonged Sitting on Metabolic Flexibility". The investigators propose in this project to determine the effect of 3 days of frequent interruption of prolonged sitting on metabolic health in healthy overweight sedentary adults (n=24), as compared to 3 days including a single long bout of isocaloric exercise or a control condition where subjects...

What is the current status of trial NCT02258438?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2014-10-08. Estimated completion is 2017-09.

What interventions are being tested in trial NCT02258438?

The interventions under investigation include: Uninterrupted sitting (BEHAVIORAL), Sitting + 1 bout of activity (BEHAVIORAL), Sitting + microbursts of activity (BEHAVIORAL).

Who is sponsoring clinical trial NCT02258438?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02258438's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02258438, the US trial registry maintained by the National Library of Medicine. NCT02258438 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.